| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 44.66B | 52.99B | 46.18B | 37.34B | 43.15B | 51.42B |
| Gross Profit | 12.21B | 14.73B | 12.13B | 10.61B | 10.95B | 15.49B |
| EBITDA | 3.34B | 4.72B | 2.99B | 2.20B | 2.63B | 7.18B |
| Net Income | 791.00M | 2.30B | 800.00M | 778.00M | 260.00M | 4.20B |
Balance Sheet | ||||||
| Total Assets | 71.13B | 73.05B | 73.55B | 76.03B | 71.39B | 72.60B |
| Cash, Cash Equivalents and Short-Term Investments | 23.13B | 29.48B | 26.67B | 23.10B | 26.73B | 27.90B |
| Total Debt | 19.34B | 21.11B | 21.24B | 20.43B | 18.29B | 13.55B |
| Total Liabilities | 38.44B | 36.80B | 39.96B | 41.39B | 37.50B | 38.06B |
| Stockholders Equity | 32.63B | 36.17B | 33.50B | 34.37B | 33.60B | 34.17B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.68B | 4.33B | -5.28B | -4.22B | -640.00M |
| Operating Cash Flow | 0.00 | 5.75B | 5.34B | -4.76B | -3.28B | 1.41B |
| Investing Cash Flow | 0.00 | -1.70B | -1.47B | -254.00M | -1.16B | -1.55B |
| Financing Cash Flow | 0.00 | -1.56B | -471.00M | 1.34B | 2.75B | -5.84B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥17.68T | 24.82 | 12.80% | 0.78% | 10.40% | 11.67% | |
81 Outperform | ¥159.12B | 14.32 | ― | 3.23% | 5.32% | -3.12% | |
76 Outperform | ¥321.36B | 13.22 | ― | 2.04% | -8.82% | 18.33% | |
72 Outperform | ¥813.87B | 20.14 | 4.03% | 2.25% | 5.36% | -24.06% | |
65 Neutral | ¥49.80B | 16.90 | 6.12% | 2.67% | 14.75% | 183.28% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | ¥1.06T | 30.61 | 2.99% | 2.62% | -4.29% | 75.25% |